Generally speaking, cancer stem cell maintenance by LIF and LIFR seem to follow a similar trend as that seen in mESCs: LIF signaling leads to the activation of STAT3, which increases the stem cell like properties in solid tumors through transcriptional regulators. This evidence concerns the gene STAT3 and cancer.